DIOSynVax

Hertford, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a vaccine antigen design company intended to accelerate vaccine development to maximize the protection against existing and future viruses. DIOSynVax is based in Hertford, United Kingdom and was founded in 2017. Its last reported valuation was $31.6 million in Dec 2025. It has raised $9.8 million.

Last reported valuation
$31.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
—

Who backs DIOSynVax?

7 investors
InvestorType
Innovate UKOther
Gates FoundationOther
Parkwalk AdvisorsVenture capital
Coalition for Epidemic Preparedness InnovationsOther
Flu lab—
UK Department of Health—
University of Cambridge—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

DIOSynVax investors

7 investors are on record for DIOSynVax, including Innovate UK, Gates Foundation, Parkwalk Advisors and Coalition for Epidemic Preparedness Innovations.

Private Market View
More of DIOSynVax with a free Private Market View account
  • ·Watch DIOSynVax: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like DIOSynVax. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View